d’Abadie, P.; Gheysens, O.; Lhommel, R.; Jamar, F.; Kirchgesner, T.; Mazzeo, F.; Coubeau, L.; Yildiz, H.; De Roo, A.-K.; Schubert, T.
Diagnostic Superiority of Dual-Time Point [18F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors. Diagnostics 2023, 13, 3202.
https://doi.org/10.3390/diagnostics13203202
AMA Style
d’Abadie P, Gheysens O, Lhommel R, Jamar F, Kirchgesner T, Mazzeo F, Coubeau L, Yildiz H, De Roo A-K, Schubert T.
Diagnostic Superiority of Dual-Time Point [18F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors. Diagnostics. 2023; 13(20):3202.
https://doi.org/10.3390/diagnostics13203202
Chicago/Turabian Style
d’Abadie, Philippe, Olivier Gheysens, Renaud Lhommel, François Jamar, Thomas Kirchgesner, Filomena Mazzeo, Laurent Coubeau, Halil Yildiz, An-Katrien De Roo, and Thomas Schubert.
2023. "Diagnostic Superiority of Dual-Time Point [18F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors" Diagnostics 13, no. 20: 3202.
https://doi.org/10.3390/diagnostics13203202
APA Style
d’Abadie, P., Gheysens, O., Lhommel, R., Jamar, F., Kirchgesner, T., Mazzeo, F., Coubeau, L., Yildiz, H., De Roo, A.-K., & Schubert, T.
(2023). Diagnostic Superiority of Dual-Time Point [18F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors. Diagnostics, 13(20), 3202.
https://doi.org/10.3390/diagnostics13203202
